Eagle Health Investments LP - Q3 2023 holdings

$454 Million is the total value of Eagle Health Investments LP's 23 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 0.0% .

 Value Shares↓ Weighting
DHR BuyDANAHER CORPORATION$43,438,589
+5.2%
175,085
+1.7%
9.57%
+24.0%
LNTH BuyLANTHEUS HLDGS INC$28,952,316
+36.3%
416,700
+64.6%
6.38%
+60.6%
DXCM BuyDEXCOM INC$25,760,597
+23.4%
276,105
+70.0%
5.68%
+45.5%
TMDX BuyTRANSMEDICS GROUP INC$22,677,724
+16.4%
414,205
+78.5%
5.00%
+37.2%
SRPT BuySAREPTA THERAPEUTICS INC$21,117,979
+89.4%
174,212
+79.0%
4.65%
+123.3%
INSP BuyINSPIRE MED SYS INC$18,503,141
-21.8%
93,243
+28.0%
4.08%
-7.8%
OM BuyOUTSET MED INC$16,260,312
-38.1%
1,494,514
+24.5%
3.58%
-27.0%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-10-27
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
IQVIA HLDGS INC12Q3 20239.6%
UNITED THERAPEUTICS CORP DEL12Q3 20238.7%
ALNYLAM PHARMACEUTICALS INC12Q3 20238.5%
NATERA INC12Q3 20238.5%
ARGENX SE12Q3 20237.0%
DEXCOM INC12Q3 20235.7%
OUTSET MED INC12Q3 20237.3%
AGIOS PHARMACEUTICALS INC12Q3 20237.2%
ADAPTIVE BIOTECHNOLOGIES COR12Q3 20235.1%
GUARDANT HEALTH INC12Q3 20233.8%

View Eagle Health Investments LP's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-12
13F-HR2023-10-27
13F-HR2023-08-14
13F-HR2023-05-12
13F-HR2023-02-13
13F-HR2022-11-14
13F-HR2022-08-11
13F-HR2022-05-12
13F-HR2022-02-10
13F-HR2021-10-20

View Eagle Health Investments LP's complete filings history.

Compare quarters

Export Eagle Health Investments LP's holdings